コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 many different interactions (for example in pharmaceutical research).
2 ructured data have opened a new paradigm for pharmaceutical research.
3 vant to basic science, clinical medicine and pharmaceutical research.
4 ut commonly disregarded in some areas of non-pharmaceutical research.
5 cells) is extensively used in biomedical and pharmaceutical research.
6 mass spectrometry imaging (MALDI-MSI) within pharmaceutical research.
7 rating tools has emerged at the forefront of pharmaceutical research.
8 behind these complex phenomena is crucial in pharmaceutical research.
9 eoselectively deuterated building blocks for pharmaceutical research.
10 the potential to complement such methods in pharmaceutical research.
11 a valuable tool in thiol-related biomedical/pharmaceutical research.
12 cs with heteroaromatic azoles of interest in pharmaceutical research.
13 coefficient (D) is a crucial measurement in pharmaceutical research.
14 portant large animal model in biomedical and pharmaceutical research.
15 arity measures to identify new compounds for pharmaceutical research.
16 he untargeted metabolomic approaches used in pharmaceutical research.
17 or siRNAs is a mainstay of both academic and pharmaceutical research.
18 nd noteworthy acceptance of the technique in pharmaceutical research.
19 c studies on catalyst formation processes in pharmaceutical research.
20 as isosteres of purine, are of interest for pharmaceutical research.
21 RF) peptide family is an important target in pharmaceutical research.
22 a number of applications in diagnostics and pharmaceutical research.
23 nostic genes, and thus are prime targets for pharmaceutical research.
24 ing diseases, they represent key targets for pharmaceutical research.
25 th growing applications in biotechnology and pharmaceutical research.
26 an important role in medicinal chemistry and pharmaceutical research.
27 c DNA sequencing pipelines of biomedical and pharmaceutical research.
28 effect on the transcriptome is a key area of pharmaceutical research.
29 nificance in synthetic organic chemistry and pharmaceutical research.
30 aturation are main issues in biochemical and pharmaceutical research.
31 ial role in life science, bioanalytical, and pharmaceutical research.
32 ore, to benefit personalized health care and pharmaceutical research.
33 Moreover, the marked increase in clinical pharmaceutical research addressing SCD and the new and o
34 the inhibitory G protein (G(i)) is vital for pharmaceutical research aimed at finding treatments for
35 cal databases are increasingly available for pharmaceutical research, allowing for deep characterizat
36 as provides a tool for targeted experimental pharmaceutical research and clinical trials to improve d
37 power of multiplatform MSI analysis within a pharmaceutical research and development (R&D) environmen
39 Genomics will succeed in revolutionising pharmaceutical research and development only if these in
40 t activities has become standard practice in pharmaceutical research and development, and regulatory
49 strates the vast potential of MALDI-2-MSI in pharmaceutical research and drug development and provide
50 ies.(1) These plants are pivotal for ongoing pharmaceutical research and drug development,(1)(,)(2)(,
51 fety concern encountered by project teams in pharmaceutical research and has the potential to stop pr
52 German Federal Ministry of Health and by the Pharmaceutical Research and Manufacturers Association of
53 red by the Food and Drug Administration, the Pharmaceutical Research and Manufacturers Association, a
54 lites in Safety Testing) committee of PhRMA (Pharmaceutical Research and Manufacturers of America) ha
55 Risk Action Team framework developed by the Pharmaceutical Research and Manufacturers of America, an
56 ewable resources, with a potential impact on pharmaceutical research and molecular design and deliver
59 n for in vivo applications is a milestone in pharmaceutical research and protein-drug development.
60 tions of drug effects in humans will advance pharmaceutical research and speed up clinical trials.
61 ful tools for high-throughput biomedical and pharmaceutical research and the advancement of proteomic
62 l offers a fresh perspective to clinical and pharmaceutical research and therapeutic applications of
63 complex mixtures, such as those relevant to pharmaceutical research, and quantitative aspects of LIA
64 show great promise for basic biomedical and pharmaceutical research, and robust and portable point-o
65 ith wide-ranging applications in medical and pharmaceutical research as well as clinical workflows.
66 chemical libraries are increasingly used in pharmaceutical research because they enable the rapid di
67 the focus of a significant amount of current pharmaceutical research because they play a key role in
68 he fundamental basis for molecular design in pharmaceutical research, biocatalysis, and agrochemical
69 transformative technology that is advancing pharmaceutical research by producing personalized drug p
70 PC of PM represents an area where additional pharmaceutical research can assist further development a
72 owth in attention from both the academic and pharmaceutical research communities over the past few ye
74 , Inc., Cambridge, MA, and Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan,
75 asis for its broad successful application in pharmaceutical research, development, and manufacturing.
79 crucial in biology, chemistry, physics, and pharmaceutical research, enabling the detection of heat
82 ce, continuous technological development and pharmaceutical research has led to tremendous progress i
84 osteric modulators, an active area of modern pharmaceutical research, has proved challenging because
85 t of PM patient management, there is limited pharmaceutical research in this treatment setting (e.g.,
86 is under development at Bristol-Myers Squibb Pharmaceutical Research Institute for the treatment of h
88 uestion mark4-HPR, Fenretinide; R.W. Johnson Pharmaceutical Research Institute, Springhouse, PA) and
89 rmacogenomics, DNA microarrays, etc.) drives pharmaceutical research into individual diseases of old
91 ion mass spectrometry imaging (MALDI-MSI) in pharmaceutical research is strongly dependent on the det
95 ort processes remains a serious challenge in pharmaceutical research, particularly the transport of u
96 thod has extensive potential in clinical and pharmaceutical research, particularly where sensitive an
97 y and directed evolution are central to many pharmaceutical research programs, yet the lack of robust
100 natural 13C abundance; this matches typical pharmaceutical research settings in which ligand isotope
102 been identified as an attractive target for pharmaceutical research that is directed at the discover
103 Cancer cells have been increasingly grown in pharmaceutical research to understand tumorigenesis and
104 mic sequencing, payor records, and data from pharmaceutical research, wearables, and medical devices.
105 erivatives that are of potential interest to pharmaceutical research were synthesized within minutes
106 drug discovery has a strong track record in pharmaceutical research, yet public domain data indicate